64
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine

, , , , &
Pages 437-445 | Published online: 15 Sep 2015

References

  • AlbertiKGZimmetPShawJIDF Epidemiology Task Force Consensus GroupThe metabolic syndrome: a new worldwide definitionLancet200536694911059 106216182882
  • International Diabetes FederationThe Idf Consensus Worldwide Definition of the Metabolic SyndromeInternational Diabetes Federation2006 Available from: http://www.idf.org/webdata/docs/idf_meta_def_final.pdfAccessed July 19, 2015
  • AlbertiKGZimmetPShawJMetabolic syndrome: a new world wide definition. A Consensus Statement from the International Diabetes FederationDiabetes Med2006235460 69
  • WellbornTAWearneKCoronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrationsDiabetes Care197622154 160
  • PyoralaKRelationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in FinlandDiabetes Care197922131 141520116
  • ModanMHalkinHKarasikALuskyAElevated serum uric acid: a facet of hyperinsulinaemiaDiabetologia1987309713 7183322912
  • ReavenGMBanting lecture 1988. Role of insulin resistance in human diseaseDiabetes198837121595 16073056758
  • VergesBLDyslipidemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesisDiabetes Metab199925Suppl 332 4010421991
  • RosolovaHThe sympathetic nervous system and insulin resistanceVintr Kek200349161 65 Czech
  • GinnerVCocaAde la SierraAIncreased insulin resistance in salt-sensitive hypertensionJ Hum Hypertens2001157481 48511464258
  • HotamisligilGSThe role of TNF-alpha and TNF receptors in obesity and insulin resistanceJ Intern Med19992456621 62510395191
  • Robert HEckelThe metabolic syndromeFauciASBraunwaldEKasperDLHauserSILongoDLJamesonJLLoscaizoJHarrison’s Principles of Internal Medicine17th edThe McGraw-Hill20081509 1513
  • Diabetes Atlas2nd editionInternational Diabetes Federation2003
  • TurnerRCullCHolmanRUnited Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitusAnn Intern Med19961241 Pt 2136 1458554206
  • SternMPHaffnerSMDyslipidaemia in type II diabetes. Implications for therapeutic interventionDiabetes Care19914121144 11591773701
  • BuseJBPolonoskyKSBurantCFType 2 Diabetes MellitusKronenbergMelmedPolonoskyWilliams Textbook of Endocrinology11th edPhiladelphia, PASaunders Elsevier20081329 1372
  • BalkauBShipleyMJarrettRJHigh blood glucose concentrations is a risk factor for mortality in middle-aged non diabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen StudyDiabetes Care1998213360 36779540016
  • BalletshoferBMRittigKEnderleMDEndothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistanceCirculation2000101151780 178410769277
  • ScuteriATesauroMRizzaSEndothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndromeNutr Metab Cardiovasc Dis2008185349 45617935958
  • HopkinsKDLehmannEDJonesRLTurayRCGoslingRGA family history of NIDDM is associated with decreased aortic distensibility in normal healthy young adult subjectsDiabetes Care1996195501 5038732717
  • EschwegeERichardJLThibultNCoronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris prospective study, ten years laterHorm Metab Res Suppl19851541 463908280
  • GroopLForsblomCLehtovirtaMMetabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effectsDiabetes199645111585 15938866565
  • SarlundHPyöräläKPenttiläILaaksoMEarly abnormalities in coronary heart disease risk factors in relatives of subjects with non- insulin-dependent diabetesArterioscler Thromb1992126657 6631591229
  • GürlekABayraktarMKirazliSIncreased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levelsDiabetes Care200023188 9210857975
  • De MarcoMde SimoneGRomanMJCardiac geometry and function in diabetic or pre-diabetic adolescents and young adults: the Strong Heart StudyDiabetes Care201134102300 230521873564
  • VelagaletiRSGonaPChuangMLRelations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart StudyCirc Cardiovasc Imaging201033257 26320208015
  • LeeSCowanPAWetzelGTVelasquez-MieyerPPrediabetes and blood pressure effects on heart rate variability, QT-interval duration, and left ventricular hypertrophy in overweight-obese adolescentsJ Pediatr Nurs2011265416 42721930028
  • GemalmazAAydinSBasakOPrevalence of the metabolic syndrome in a rural Turkish population: comparison and concordance of two diagnostic criteriaTurk J Med Sci20083821659 1165
  • KatibiIAAkandeAASalamiAKMetabolic Syndrome among type 2 diabetes mellitus patients: Our experience in Ilorin, NigeriaThe Nigerian Journal of General Practice200371 5
  • MunaWFCardiovascular disorders in AfricaWorld Health Stat Q1993462125 1338303907
  • Dagogo-JackSOdiaOJMyocardial infarction in Nigerian AfricansOrient J Med19902129 132
  • DanbauchiSSOnyemelukweGCIschaemic Heart Disease in Nigerians. Report of two casesDiabetes International20011059 60
  • HirohitoSSachikoMHitomiFYukioYYoshimitsuYShunIShigehiroKIs the Diagnosis of Metabolic Syndrome Useful for Predicting Cardiovascular Disease in Asian Diabetic Patients? Analysis from the Japan Diabetes Complications StudyDiabetes Care2005281463 147115920069
  • CullCAJensenCCRetnakaranRHolmanRRImpact of the Metabolic Syndrome on Macrovascular and Microvascular Outcomes in Type 2 Diabetes Mellitus United Kingdom Prospective Diabetes Study 78Circulation2007116192119 212617967769
  • BrunoGMerlettiFBiggeriAMetabolic Syndrome as a Predictor of All-Cause and Cardiovascular Mortality in Type 2 Diabetes: The Casale Monferrato StudyDiabetes Care200427112689 269415505006
  • Gimeno OmaJALou ArnalLMMolinero HerguedasEBoned JuliánBPortilla CórdobaDPMetabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetesRev Esp Cardiol2004576507 513 Spanish15225497
  • BonoraETargherGFormentiniGMetabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications StudyDiabet Med200021152 5814706054
  • IsomaaBAlmgrenPTuomiTCardiovascular morbidity and mortality associated with the metabolic syndromeDiabetes Care2001244683 68911315831
  • BrunoGMerlettiFBiggeriACasale Monferrato Study: Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato StudyDiabetes Care200027112689 269415505006
  • Van Der HeijdenAAOrtegonMMNiessenLWNijpelsGDekkerJMPrediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn StudyDiabetes Care200932112094 209819875606
  • KarsitoSoeatmadjiDWDiabetes and StrokeActa Med Indones2008403151 15818838754
  • KisellaBMKhouryJKleindorferDEpidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke StudyDiabetes Care2005282355 35915677792
  • GrayCSScottJFFrenchJMAlbertiKGO’ConnellJEPrevalence and prediction of unrecognized diabetes mellitus and impaired glucose tolerance following acute strokeAge Ageing200433171 7714695867
  • KullerLHStroke and diabetesDiabetes in America2nd editionBethesdaThe National Diabetes Information Clearinghouse (NDIC) of NIDDK1995449 456
  • EguchiKKarioKShimadaKGreater impact of coexistence of hypertension and diabetes on silent cerebral infarctsStroke200334102471 247414500939
  • HoJEPaultreFMoscaLWomen’s Pooling ProjectIs diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the women’s pooling projectStroke200334122812 281614657546
  • QiaoQPyöräläKTuomilehtoJGaoWHuGPeltonenMComparison of three different definitions for the metabolic syndrome in non-diabetic EuropeansThe British Journal of Diabetes and Vascular Disease20055161 168
  • QiaoQLaatikainenTZetheliusBComparison of different definitions of the metabolic syndrome in relation to the risk of developing stroke and coronary heart disease in Finnish and Swedish cohortsStroke2009402337 34319109550
  • GuzderRNGatlingWMulleeMAByrneDCImpact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetesDiabetologia200649149 5516341841
  • SeonCSMinKWLeeYSCardiovascular Risk Assessment with Vascular Function, Carotid Atherosclerosis and the UKPDS Risk Engine in Korean Patients with Newly Diagnosed Type 2 DiabetesDiabetes Metab J2011356619 62722247905
  • BannisterCAPooleCDJenkins-JonesSExternal Validation of the UKPDS Risk Engine in Incident Type 2 Diabetes: a need for new risk type 2 diabetes-specific risk equationsDiabetes Care2014372537 54524089541
  • Van DierenSPeelenLMNothlingsUExternal validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetesDiabetologia2011542264 27021076956